| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net earnings | 1,499 | 2,206 | -232 | 219 |
| Equity method earnings, net of taxes | 1,964 | 2,135 | -393 | - |
| Depreciation and amortization | 52 | 35 | 18 | 53 |
| Earnings from equity method investments, net of distributions | - | - | - | 11 |
| Gain on sales of assets | 8 | 8 | 8 | 12 |
| Stock-based compensation | 24 | 17 | 12 | 26 |
| Deferred taxes | -59 | -6 | -80 | 26 |
| Changes in assets and liabilities | -450 | 405 | 384 | -194 |
| Other | 15 | 11 | 5 | -6 |
| Operating cash flow | -21 | -307 | -286 | 501 |
| Proceeds from the sale of nuscale shares | 414 | - | - | - |
| Purchases of marketable securities | 88 | 80 | 21 | 140 |
| Proceeds from sales and maturities of marketable securities | 168 | 114 | 75 | 118 |
| Capital expenditures | 38 | 25 | 11 | 133 |
| Proceeds from sales of assets | 63 | 62 | 62 | 69 |
| Investments in partnerships and joint ventures | 203 | 135 | 69 | 66 |
| Other | 0 | -3 | - | -23 |
| Investing cash flow | 316 | -61 | 36 | -129 |
| Repurchase of common stock | 365 | 295 | 142 | - |
| Purchase and retirement of debt | 37 | 36 | 18 | 44 |
| Proceeds from issuance of 2029 notes, net of issuance costs | - | - | - | 0 |
| Capped call transaction related to 2029 notes | - | - | - | 0 |
| Dividends paid on cps | - | - | - | 0 |
| Make-whole payment on conversion of cps | - | - | - | 0 |
| Distributions paid to nci | 43 | - | - | 8 |
| Capital contributions by nci | 65 | - | - | 0 |
| Proceeds from nuscale share issuance (net of issuance fees) | 0 | 0 | - | 80 |
| Other | -8 | -10 | -3 | -6 |
| Financing cash flow | -388 | -341 | -163 | 22 |
| Effect of exchange rate changes on cash | 40 | 52 | 17 | -1 |
| Increase (decrease) in cash and cash equivalents | -53 | -657 | -396 | 393 |
| Cash and cash equivalents at beginning of period | 2,829 | 2,829 | 2,829 | 2,519 |
| Cash and cash equivalents at end of period | 2,776 | 2,172 | 2,433 | 2,912 |
FLUOR CORP (FLR)
FLUOR CORP (FLR)